AgingResearch.NewsJoin free

Community gathering place participation

Exposure

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funders: Japan Agency for Medical Research and Development and others
  • Humans1

Associations

1

Functional disability or death

downin humans1OR 0.88

1 study

  1. Community gathering place participation lowers the risk of functional disability or death in humans (OR 0.88, 95% CI 0.79–0.98).

    “Participation in CGPs was associated with lower odds of the incidence functional disability or death (OR, 0.88; 95 % CI, 0.79-0.98).”

    Humansn = 55,982

    Heterogeneity in the associations of community gathering place participation with healthy ageing

    Archives of gerontology and geriatrics25 Oct 2025

Latest

Related